Biological response modifiers: interferons, interleukins, recombinant products, liposomal products (Q41747318)

8 October 2017

1 reference

title

Biological response modifiers: interferons, interleukins, recombinant products, liposomal products (English)

1 reference

8 October 2017

Kruth SA

1

1 reference

8 October 2017

1 March 1998

1 reference

Veterinary Clinics of North America: Small Animal Practice

8 October 2017

1 reference

8 October 2017

28

1 reference

8 October 2017

2

1 reference

8 October 2017

269-295

1 reference

Nucleotide and predicted peptide sequence of feline interferon-gamma (IFN-gamma).

8 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Molecular cloning and characterization of a cDNA encoding feline interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Effects of interleukin 6 on megakaryocytes and on canine platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Bioactivity of recombinant feline interleukin-2 on human and feline leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Sequence and functional characterization of feline interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Cloning and expression of the canine interferon-gamma gene

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

The isolation and sequence of canine interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Induction of serum tumor necrosis factor-alpha and interleukin-6 activity by liposome-encapsulated muramyl tripeptide-phosphatidylethanolamine (L-MTP-PE) in normal cats.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Immunophysiological studies of interleukin-2 and canine lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Induction of lymphokine-activated killer (LAK) activity in canine lymphocytes with low dose human recombinant interleukin-2 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Interleukin-6 activity in dogs with juvenile polyarteritis syndrome: effect of corticosteroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Cloning of a canine gene homologous to the human interleukin-8-encoding gene

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

The effect of Acemannan Immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Anemia of chronic renal failure in dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Cloning of the canine interleukin-2-encoding cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Effect of liposome-muramyl tripeptide combined with recombinant canine granulocyte colony-stimulating factor on canine monocyte activity

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

In vitro and in vivo canine mononuclear cell production of tumor necrosis factor induced by muramyl peptides and lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Canine osteosarcoma: amputation and chemoimmunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Therapeutic Use of Recombinant Human G-CSF (rhG-CSF) in a Canine Model of Sublethal and Lethal Whole-body Irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Molecular cloning and expression of canine interleukin 8 cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Inhibitory effects of recombinant feline interferon on the replication of feline enteropathogenic viruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Molecular cloning of feline interferon cDNA by direct expression

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Evaluation of recombinant canine granulocyte colony-stimulating factor as an inducer of granulopoiesis. A pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Effect of recombinant canine granulocyte colony-stimulating factor on peripheral blood neutrophil counts in normal cats

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Hematopoietic growth factors: frontiers for cure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Use of recombinant canine granulocyte colony-stimulating factor to decrease myelosuppression associated with the administration of mitoxantrone in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Molecular cloning of feline interleukin-6 cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Preventive effects of recombinant human erythropoietin administration on anemia associated with repeated hemodialysis in nephrectomized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Canine plasma erythropoietin levels in 124 cases of anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Evaluation of erythropoietin production in dogs with reduced functional renal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Cloning, expression and characterization of biologically active feline tumour necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

A canine febrile disorder associated with elevated interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Feline interferon production in silkworm by recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Molecular cloning and expression of cat interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Molecular cloning of cat interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Muramyl peptides augment the in vitro and in vivo cytostatic activity of canine plastic-adherent mononuclear cells against canine osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Effects of interleukin-1 alpha on migration of canine neutrophils in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Pharmacokinetic properties of recombinant feline interferon and its stimulatory effect on 2',5'-oligoadenylate synthetase activity in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Homogeneous production of feline interferon in silkworm by replacing single amino acid code in signal peptide region in recombinant baculovirus and characterization of the product

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Clinical applications of hematopoietic growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Effect of recombinant human interferon-alpha in vitro and in vivo on mitogen-induced lymphocyte blastogenesis in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Pilot study of the effect of acemannan in cats infected with feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Reversal of feline leukemia virus infection by adoptive transfer of lectin/interleukin-2-activated lymphocytes, interferon-alpha, and zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Production and characterization of recombinant canine interferon-gamma from Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

Cloning of the cDNA for canine interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2898%2982005-6

7 January 2021

10.1016/S0195-5616(98)82005-6

Identifiers

DOI

1 reference

8 October 2017

1 reference

PubMed ID

9556849